MedTrace Logo

The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade

NCT01545193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-09-16

Study results available
· View outcomes & findings →

Summary

Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is uncertain whether certain patient populations are at greater risk for this common anesthetic complication. However, it is possible that elderly surgical patients may exhibit a higher incidence of residual neuromuscular blockade. The aim of this clinical trial is to determine the incidence of residual neuromuscular blockade in a cohort of younger (ages 18-50) and older (ages 70-90) patients undergoing surgery and general anesthesia.

Conditions

  • Residual Neuromuscular Blockade in Elderly Patients

Interventions

OTHER

Age and incidence of residual neuromuscular blockade

An older cohort is anticipated to have a higher incidence of residual neuromuscular blockade

Sponsors & Collaborators

  • Endeavor Health

    lead OTHER

Principal Investigators

  • Glenn S. Murphy, MD · Endeavor Health

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545193 on ClinicalTrials.gov